These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 30547439)
21. Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing. Lim H; Poleksic A; Yao Y; Tong H; He D; Zhuang L; Meng P; Xie L PLoS Comput Biol; 2016 Oct; 12(10):e1005135. PubMed ID: 27716836 [TBL] [Abstract][Full Text] [Related]
22. A New Method for Computational Drug Repositioning Using Drug Pairwise Similarity. Li J; Lu Z Proceedings (IEEE Int Conf Bioinformatics Biomed); 2012; 2012():1-4. PubMed ID: 25264495 [TBL] [Abstract][Full Text] [Related]
23. DRTerHGAT: A drug repurposing method based on the ternary heterogeneous graph attention network. He H; Xie J; Huang D; Zhang M; Zhao X; Ying Y; Wang J J Mol Graph Model; 2024 Jul; 130():108783. PubMed ID: 38677034 [TBL] [Abstract][Full Text] [Related]
24. Recommendation Techniques for Drug-Target Interaction Prediction and Drug Repositioning. Alaimo S; Giugno R; Pulvirenti A Methods Mol Biol; 2016; 1415():441-62. PubMed ID: 27115647 [TBL] [Abstract][Full Text] [Related]
25. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm. Luo H; Wang J; Li M; Luo J; Peng X; Wu FX; Pan Y Bioinformatics; 2016 Sep; 32(17):2664-71. PubMed ID: 27153662 [TBL] [Abstract][Full Text] [Related]
26. NEDD: a network embedding based method for predicting drug-disease associations. Zhou R; Lu Z; Luo H; Xiang J; Zeng M; Li M BMC Bioinformatics; 2020 Sep; 21(Suppl 13):387. PubMed ID: 32938396 [TBL] [Abstract][Full Text] [Related]
27. A novel multi-modal drug repurposing approach for identification of potent ACK1 inhibitors. Phatak SS; Zhang S Pac Symp Biocomput; 2013; ():29-40. PubMed ID: 23424109 [TBL] [Abstract][Full Text] [Related]
28. Methods for Discovering and Targeting Druggable Protein-Protein Interfaces and Their Application to Repurposing. Ozdemir ES; Halakou F; Nussinov R; Gursoy A; Keskin O Methods Mol Biol; 2019; 1903():1-21. PubMed ID: 30547433 [TBL] [Abstract][Full Text] [Related]
29. Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity. Tan F; Yang R; Xu X; Chen X; Wang Y; Ma H; Liu X; Wu X; Chen Y; Liu L; Jia X Mol Biosyst; 2014 May; 10(5):1126-38. PubMed ID: 24603772 [TBL] [Abstract][Full Text] [Related]
30. Computational drug repositioning with attention walking. Park JH; Cho YR Sci Rep; 2024 May; 14(1):10072. PubMed ID: 38698208 [TBL] [Abstract][Full Text] [Related]
31. Drug repositioning based on the heterogeneous information fusion graph convolutional network. Cai L; Lu C; Xu J; Meng Y; Wang P; Fu X; Zeng X; Su Y Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34378011 [TBL] [Abstract][Full Text] [Related]
32. Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform. Hudson ML; Samudrala R Molecules; 2021 Apr; 26(9):. PubMed ID: 33925237 [TBL] [Abstract][Full Text] [Related]
33. Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction. Coelho ED; Arrais JP; Oliveira JL PLoS Comput Biol; 2016 Nov; 12(11):e1005219. PubMed ID: 27893735 [TBL] [Abstract][Full Text] [Related]
34. Predicting drug-disease interactions by semi-supervised graph cut algorithm and three-layer data integration. Wu G; Liu J; Wang C BMC Med Genomics; 2017 Dec; 10(Suppl 5):79. PubMed ID: 29297383 [TBL] [Abstract][Full Text] [Related]
35. BiRWDDA: A Novel Drug Repositioning Method Based on Multisimilarity Fusion. Yan CK; Wang WX; Zhang G; Wang JL; Patel A J Comput Biol; 2019 Nov; 26(11):1230-1242. PubMed ID: 31140857 [No Abstract] [Full Text] [Related]
36. Drug-Induced Expression-Based Computational Repurposing of Small Molecules Affecting Transcription Factor Activity. Gayvert K; Elemento O Methods Mol Biol; 2019; 1903():179-184. PubMed ID: 30547442 [TBL] [Abstract][Full Text] [Related]
37. Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential. Lo YC; Senese S; France B; Gholkar AA; Damoiseaux R; Torres JZ Sci Rep; 2017 Sep; 7(1):11261. PubMed ID: 28900159 [TBL] [Abstract][Full Text] [Related]
38. DrPOCS: Drug Repositioning Based on Projection Onto Convex Sets. Wang YY; Cui C; Qi L; Yan H; Zhao XM IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(1):154-162. PubMed ID: 29993698 [TBL] [Abstract][Full Text] [Related]
39. Drug Repurposing Using Deep Embeddings of Gene Expression Profiles. Donner Y; Kazmierczak S; Fortney K Mol Pharm; 2018 Oct; 15(10):4314-4325. PubMed ID: 30001141 [TBL] [Abstract][Full Text] [Related]
40. Prediction of drug indications based on chemical interactions and chemical similarities. Huang G; Lu Y; Lu C; Zheng M; Cai YD Biomed Res Int; 2015; 2015():584546. PubMed ID: 25821813 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]